Nova Patents
CA2560892C

Magnetic nanoparticles of noble metals

Abstract

The invention relates to nanoparticles of noble metals, having a controlled microstructure which leads to the appearance of ferromagnetic behaviour in said nanoparticles, thereby enabling the use of very small magnets (< 5 nm) in a range in which standard ferromagnetic metals behave as superparamagnetic entities (disappearance of hysteresis cycle). The inventive nanoparticles can be used, for example, to reduce the dimensions in magnetic recordings, as well as in biomedicine as tools for biomolecule recognition, nuclear magnetic resonance imaging, drug-release control or hypothermia treatments.

CA2560892C, drawing sheet 1
Sheet 1 of 8

Term

Term ended

Expired 23 March 2025, 1.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

20 claims: 9 independent, 11 dependent

  1. 1
    CA 02560892 2012-04-12 The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:1. A magnetic nanoparticle of a noble metal which is Au, Pd, Pt or Ag, the nanoparticle having a size of less than 5 nm, comprising: a) a core formed from said noble metal;and b) an anisotropic crust formed from compounds containing at least one metal-sulphur covalent bond, wherein the nanoparticle displays ferromagnetic behaviour at room temperature and a hysteresis cycle.
  2. 7
    A nanoparticle according to any one of claims 1 to 6, wherein the nanoparticle displays a ferromagnetic behaviour with low coercive field. CA 02560892 2012-04-12
  3. 8
    A process for preparation of the nanoparticle as defined in any one of claims 1 to 7, comprising the reaction of a precursor of the non-magnetic noble metal with a thiol derivative of general formula HS-R in stoichiometric excess and in the presence of a reducing agent.
  4. 11
    Use of the nanoparticle as defined in any one of claims 1 to 7 for magnetic recording.
  5. 12
    Use of the nanoparticle as defined in any one of claims 1 to 7 in a device for the controlled release of drugs.
  6. 13
    A nanoparticle according to any one of claims 1 to 7, for use in a method of hyperthermia treatment.
  7. 14
    A nanoparticle according to any one of claims 1 to 7, for use in a method of improving the imaging in nuclear magnetic resonance.
  8. 15
    Use of the nanoparticle as defined in any one of claims 1 to 7 as a biosensor.
  9. 16
    Use of the nanoparticle as defined in any one of claims 1 to 7 in magnetic printing.
  10. 17
    Use of the nanoparticle as defined in any one of claims 1 to 7 in magnetooptical applications. CA 02560892 2012-04-12
  11. 18
    Use of the nanoparticle as defined in any one of claims 1 to 7 in coding applications.
  12. 19
    A system which contains a population of one or more of the nanoparticles as defined in any one of claims 1 to 7.